Vendor: Advanced Accelerator Applications USA, Incorporated
Change Order Amount: $370,000
The use of AAA USA's injectable tracer for molecular nuclear medicine diagnostics and therapeutics has increased vastly since exemption 415IDM was awarded February 5, 2019. The end date of the term is extended to June 30, 2025 as well. The amount is now an estimated $550,000.
The buyer for this procurement is now Ian Masterton, (312) 996-2801.
The Chief Procurement Officer for this procurement is now Ben Bagby.
The University award process may be delayed up to thirty days as this award goes through a state approval process.